Can I Be Honest With My Neurologist? A Problem of Health Technology Assessment in Canada
- 8 November 2023
- journal article
- editorial
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 51 (5) , 603-605
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Early initiation of riluzole may improve absolute survival in amyotrophic lateral sclerosisMuscle & Nerve, 2022
- Diagnostic criteria in amyotrophic lateral sclerosis: Time for a changeMuscle & Nerve, 2022
- Progressive Neurochemical Abnormalities in Cognitive and Motor Subgroups of Amyotrophic Lateral SclerosisNeurology, 2021
- Edaravone for amyotrophic lateral sclerosis: barriers to access and lifeboat ethicsCanadian Medical Association Journal, 2020
- Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging studyThe Lancet Neurology, 2018